Clinical trial
BIomarkers to Predict the Outcomes of Sepsis
NCT05842980 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIomarkers to Predict the Outcomes of Sepsis
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2020
- Completion date
- June 1, 2025
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.